Filing Details
- Accession Number:
- 0001127602-14-028209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-19 17:21:58
- Reporting Period:
- 2014-09-17
- Filing Date:
- 2014-09-19
- Accepted Time:
- 2014-09-19 17:21:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376545 | G Gordon Pugh | 852 Winter St. Waltham MA 02451 | Svp, Coo & Cro, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-09-17 | 1,977 | $11.74 | 34,504 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2014-09-17 | 12,923 | $16.55 | 47,427 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-09-17 | 14,900 | $45.04 | 32,527 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2014-09-17 | 1,977 | $0.00 | 1,977 | $11.74 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2014-09-17 | 12,923 | $0.00 | 12,923 | $16.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,517 | 2020-05-17 | No | 4 | M | Direct | |
| 97,077 | 2013-05-21 | 2022-05-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 5,000 | Indirect | Gordon G. Pugh Revocable Trust - 2012 |
| Ordinary Shares | 15,000 | Indirect | Nancy E. Pugh Revocable Trust - 2012 |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.
- Shares subject to the stock option award vest in four equal annual installments commencing on 5/21/13.
Billionaire Hedge Funds
